One of the more exciting young forwards in the NBA will be out for a while. John Collins of the Atlanta Hawks has been suspended by the league for 25 games.
Collins violated the league’s anti-drug policy. Per a report by ESPN’s Adrian Wojnarowski, he tested positive for Growth Hormone Releasing Peptide 2.
The Hawks were last in action on Thursday, when they fell to the Miami Heat 106-97. It was the third straight loss for the team, after it started 2-0 to begin the season.
Collins tested positive for Growth Hormone Releasing Peptide 2, league says. https://t.co/p8rVl51PT8
— Adrian Wojnarowski (@wojespn) November 5, 2019
Collins’ numbers through five games have been rock solid, showing some solid development in important areas from his first two years in the league.
Through the Hawks’ five games, he is averaging 17 points, a team high 8.8 rebounds, and two blocks per game. Perhaps most encouraging, Collins has hit 47.4-percent of his three pointers, up from 34.8-percent last season, with a bump up to 3.8 attempts per game, from 2.6 a year ago.
With the 25 game suspension, Collins will be eligible to return on Dec. 23, when the team travels to play the Cleveland Cavaliers. This is a big setback for the high-flying forward, and his young teammates.
John Collins and Trae Young, who is averaging just under 27 points per game this year, look to be one of the most exciting young guard-forward combinations in the game.
Hopefully the 22-year old Wake Forest product cna bounce back from this, and it isn’t a long term setback for his career.